Access cutting-edge copd treatment through this clinical trial at a research site in Lexington. Study-provided care at no cost to qualified participants.
Access copd specialists in Lexington at no cost
This study follows strict safety protocols and ethical guidelines
All study-related copd treatment provided free
Researchers are looking for ways to treat pulmonary hypertension (PH) caused by chronic obstructive pulmonary disease (COPD). The goal of the study is to learn if people who take frespaciguat can walk farther in 6 minutes at Week 24 compared to people who take placebo.
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this copd clinical trial in Lexington, KY
If you're searching for copd treatment options in Lexington, KY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lexington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.